- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Tislelizumab
Total 437 results
-
PureTechRecruitingHead and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Solid Tumor | Metastatic Cancer | Urothelial CarcinomaUnited States
-
Ming ZhaoRecruitingRecurrent Hepatocellular CarcinomaChina
-
Zhongda HospitalRecruitingHepatocellular CarcinomaChina
-
Sun Yat-sen UniversityRecruiting
-
BeiGeneRecruitingAdvanced Solid TumorChina, United States, Australia, New Zealand, Korea, Republic of
-
Western Sydney Local Health DistrictBristol-Myers Squibb; University of Western SydneyRecruitingMelanoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Gastric Cancer | Mesothelioma | Endometrial Cancer | Lung Cancer, Nonsmall CellAustralia
-
Cancer Institute and Hospital, Chinese Academy...RecruitingSmall Cell Lung CarcinomaChina
-
Sun Yat-sen UniversityRecruitingRecurrent Hepatocellular CarcinomaChina
-
The First Affiliated Hospital with Nanjing Medical...RecruitingBladder Urothelial CarcinomaChina
-
Sun Yat-sen UniversityRecruitingBladder Cancer Stage IVChina
-
Shanghai Pulmonary Hospital, Shanghai, ChinaRecruiting
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingTriple-negative Breast CancerChina
-
BeiGeneRecruitingClassical Hodgkin LymphomaChina
-
Fudan UniversityNot yet recruiting
-
Antengene CorporationRecruitingPeripheral T-cell Lymphoma | NK/T-cell LymphomaChina
-
Shanghai Chest HospitalRecruitingNon Small Cell Lung CancerChina
-
BeiGeneRecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Advanced Solid Tumor | Diffuse Large B Cell Lymphoma | Small Lymphocytic LymphomaAustralia, China
-
National Taiwan University HospitalNational Taiwan University Hospital, Yun-Lin BranchRecruitingAdvanced Hepatocellular CarcinomaTaiwan
-
BeiGeneRecruitingB-cell MalignanciesChina, Italy, United States, Spain, United Kingdom, Poland, Czechia, Netherlands, Greece, France, Sweden, Korea, Republic of, Turkey
-
BeiGeneRecruiting
-
BeiGeneRecruitingLocally Advanced or Metastatic Solid Tumors for Phase 1,Dose Escalation and Phase 2 Safety Lead-in, HNSCC, NSCLC and RCC Participants for Phase 2Australia, United States, Spain, France, Italy, Korea, Republic of, Poland
-
BeiGeneRecruitingMSI-H/dMMR Solid TumorsChina
-
BeiGeneActive, not recruitingGastric, or Gastroesophageal Junction AdenocarcinomaUnited States, China, Spain, Korea, Republic of, Poland, Russian Federation, Taiwan, France, Turkey, Japan, Italy, United Kingdom, Puerto Rico
-
Grupo Español Multidisciplinar de MelanomaMirati Therapeutics Inc.; BeiGeneActive, not recruiting
-
BeiGeneCompletedNon-small Cell Lung CancerChina, Russian Federation, New Zealand, Lithuania, Turkey, Brazil, Bulgaria, Poland, Mexico, Slovakia
-
BeiGeneCompletedHepatocellular Carcinoma | Unresectable Hepatocellular Carcinoma | Metastatic Hepatocellular CarcinomaChina
-
BeiGeneActive, not recruitingNon Small Cell Lung Cancer | Advanced Solid Tumor | Head and Neck Squamous Cell Carcinoma (HNSCC) | Nasopharyngeal Carcinoma (NPC)Canada, Australia, New Zealand, Korea, Republic of, United States, Malaysia, Thailand
-
Seoul National University HospitalBeiGeneActive, not recruitingAdvanced Biliary Tract CancerKorea, Republic of
-
Sun Yat-sen UniversityWuzhou Red Cross Hospital; Hunan Cancer Hospital; Cancer Hospital of Guizhou... and other collaboratorsActive, not recruiting
-
Enlivex Therapeutics RDO Ltd.TerminatedSolid Tumor | Peritoneal Cancer | Peritoneal MetastasesIsrael, Spain
-
BeiGeneActive, not recruitingEsophageal Squamous Cell Carcinoma (ESCC)China
-
BeiGeneActive, not recruitingEsophageal Squamous Cell Carcinoma (ESCC)United States, China, Spain, Australia, Czechia, Japan, Belgium, Korea, Republic of, Italy, Germany, France, Romania, Poland, United Kingdom, Russian Federation, Taiwan
-
Wuhan Union Hospital, ChinaBeiGeneActive, not recruitingNeoadjuvant Therapy | Esophagus CancerChina
-
BeiGeneCompletedEsophageal Squamous Cell CarcinomaKorea, Republic of, Spain, China, Thailand, Taiwan, France
-
BeiGeneActive, not recruitingBreast Cancer | Gastric Cancer | Gastroesophageal Junction CancerChina, Taiwan, Korea, Republic of
-
BeiGeneHutchison Medipharma LimitedCompletedAdvanced Solid TumorsKorea, Republic of, China
-
Qiu GuoqinEnrolling by invitationEsophageal Squamous Cell CarcinomaChina
-
Novartis PharmaceuticalsActive, not recruitingMetastatic Colorectal CancerCanada, Taiwan, Belgium, Germany, Spain, Italy, Czechia, Switzerland, Australia, United States, Japan, Singapore, United Kingdom, France, Israel, Hong Kong, Korea, Republic of
-
Zhou ChengzhiCompletedLung Adenocarcinoma Stage IVChina
-
Sun Yat-sen UniversitySecond Affiliated Hospital of Guangzhou Medical UniversityCompletedLiver Diseases | Hepatocellular Carcinoma | Anti-PD1 AntibodyChina
-
Xinhua Hospital, Shanghai Jiao Tong University...CompletedNatural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
BeiGeneTerminatedEsophageal Squamous Cell CarcinomaChina
-
BeiGeneActive, not recruitingLocally Advanced and Metastatic Solid TumorsChina, Taiwan, United States, Australia
-
BeiGeneCompletedA Study of Tislelizumab in Combination With Chemotherapy Versus Chemotherapy in Advanced Lung CancerNon-Small Cell Lung CancerChina
-
BeiGeneCompletedAdvanced Hepatocellular CarcinomaChina, Taiwan
-
BeiGeneEnrolling by invitationAdvanced MalignanciesChina, Taiwan, Korea, Republic of, Turkey
-
BeiGeneTerminatedNon-Small Cell Lung Cancer (NSCLC)China, Australia
-
Fujian Cancer HospitalEnrolling by invitationEGFR/ ALK-negative Advanced NSCLCChina
-
Novartis PharmaceuticalsActive, not recruitingBRAF V600 Colorectal CancerBelgium, Germany, Netherlands, Spain, Singapore, Australia, United Kingdom, Israel, Canada, United States
-
Hutchison Medipharma LimitedBeiGeneActive, not recruitingColorectal Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Solid Tumor, Unspecified, AdultUnited States